Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arroliga, M. E.
Right arrow Articles by Arroliga, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arroliga, M. E.
Right arrow Articles by Arroliga, A. C.
(Chest. 2000;118:1106-1108.)
© 2000 American College of Chest Physicians

A Pilot Study of Penicillin Skin Testing in Patients With a History of Penicillin Allergy Admitted to a Medical ICU*

Mercedes E. Arroliga, MD; William Wagner, MD, FCCP; Mary Beth Bobek, PharmD; Lori Hoffman-Hogg, MS, RN; Steven M. Gordon, MD and Alejandro C. Arroliga, MD, FCCP

* From the Section of Allergy and Immunology (Drs. M. Arroliga and Wagner), Pharmacy (Dr. Bobek), Research Education and Advanced Practice (Ms. Hoffman-Hogg), Infectious Disease (Dr. Gordon), and the Pulmonary and Critical Care Department (Dr. A. Arroliga), The Cleveland Clinic Foundation, Cleveland, OH.

Correspondence to: Alejandro C. Arroliga, MD, FCCP, 9500 Euclid Ave, G-62, Cleveland, OH 44195; e-mail: arrolia{at}ccf.org

Background: Penicillin skin testing is an accurate method to determine whether a person with a history of penicillin allergy is at risk of having an immediate reaction to penicillin. A patient with a negative reaction to a skin test may be able to use a penicillin compound safely, which could reduce the use of broad-spectrum antibiotics in this patient population.

Methods: We prospectively studied all patients with histories of penicillin allergy who were admitted to a medical ICU during a 3-month period and who received antibiotics. Skin testing was performed with benzylpenicilloyl polylysine and penicillin G. We determined the incidence of true allergy, the percentage of patients in whom antibiotic coverage was modified, and the safety of the test.

Results: Two hundred fifty-seven patients were admitted to the medical ICU of The Cleveland Clinic Foundation during the study period. Twenty-four patients (9%), labeled as penicillin allergic and receiving antibiotics, were enrolled. Three patients (13%, 3 of 21) gave histories of type I reaction to penicillin and were not skin tested. Twenty patients (95%, 20 of 21) had negative skin test reactions to penicillin and positive skin test reactions to histamine control. One patient (4%, 1 of 21) with negative skin test reactions to both penicillin and histamine control had a test dose challenge with piperacillin that was well tolerated. There were no adverse events. Antibiotic coverage was changed in 10 patients (48%) as a result of skin testing.

Conclusion: Most patients with histories of allergy to penicillin have negative reactions to skin tests and may receive penicillin safely. Penicillin skin testing can be utilized as a safe and effective strategy to reduce the use of broad-spectrum antibiotics.

Key Words: anaphylaxis • antibiotic resistance • antibiotic therapy • ICU • penicillin allergy • skin test




eLetters:

Read all eLetters

Untitled
Jim Spratt
Chest Online, 2 Nov 2000 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.